Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: A nested case-control analysis

Alexandre, Leo, Clark, Allan B., Bhutta, Hina Y., Holt, Sean, Lewis, Michael P. N. and Hart, Andrew R. (2014) Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: A nested case-control analysis. Gastroenterology, 146 (3). 661–668. ISSN 0016-5085

[img] Microsoft Word (acceptance e-mail) - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (16kB)

Abstract

Most patients with esophageal adenocarcinoma (EAC) or squamous cell cancer (ESCC) present with advanced, incurable disease. Statins have reported anti-carcinogenic effects and may be chemoprotective. We investigated the association between regular use of statins and the main histologic subtypes of esophageal malignancy (EAC, esophagogastric junctional adenocarcinoma [EGJA], and ESCC) in the UK general population.

Item Type: Article
Additional Information: Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Uncontrolled Keywords: esophageal cancer,statins,aetiology
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 20 Jan 2014 15:54
Last Modified: 02 Aug 2021 23:47
URI: https://ueaeprints.uea.ac.uk/id/eprint/46092
DOI: 10.1053/j.gastro.2013.11.046

Actions (login required)

View Item View Item